{"name":"MBX Biosciences","slug":"mbx-biosciences","ticker":"","exchange":"","domain":"mbx.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"MBX 2109","genericName":"MBX 2109","slug":"mbx-2109","indication":"Other","status":"phase_2"},{"name":"MBX 4291","genericName":"MBX 4291","slug":"mbx-4291","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"MBX 2109","genericName":"MBX 2109","slug":"mbx-2109","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"MBX 4291","genericName":"MBX 4291","slug":"mbx-4291","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2026-03-30","type":"trial","source":"simplywall.st","summary":"Assessing MBX Biosciences (MBX) Valuation After CEO Share Purchase And Phase 3 Hypoparathyroidism Plans - simplywall.st","headline":"Assessing MBX Biosciences (MBX) Valuation After CEO Share Purchase And Phase 3 Hypoparathyroidism Plans","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwJBVV95cUxQSFBPQ3NxTzJvT0tZS21oUWtXMjV3eWI4UjlfckZaY3ZYY2ZORHhoVWhRWHJnZXlKSkdGa012NmZKQ2N0SWNoUTlZeEx3SzJod2FzQmhqSkdkQVpLS2ZNM3BlWTBwVlZxalp4MzlkSWs0dktZMTEzRjMzZ0pOaVlCZzVlajBZN1l1RTM4RUR1OXFsNHE3aXZXZWZub3hncW4xS1NSMGZUSEMxQUNhcmhmQ0EzNlhNNEJ3OEQ4OVNFQUVwc3lhb0dQX21sUjNfSE1wUC1mSXN6QkJ5SUFvOVhfN0hJOUtxeFQwZW9GdW9RaF9ielpaV0R4UkhmcF9CSXd1UEpLUk50eFQ2RWttZlR3?oc=5","date":"2026-03-13","type":"pipeline","source":"The Globe and Mail","summary":"Analysts Offer Insights on Healthcare Companies: MBX Biosciences, Inc. (MBX) and REPRO-MED Systems (KRMD) - The Globe and Mail","headline":"Analysts Offer Insights on Healthcare Companies: MBX Biosciences, Inc. (MBX) and REPRO-MED Systems (KRMD)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxObWsyZ0JBb2V2eVkwZnZzNUlqU3RlVlVhanFWeTFJSzNta1ZELWQwczRWV3htSjFWYzBwNllSLWpnMWJiV0dkYUZwV2wxU1pIRjhxbGdzS1dHTkZPOGd5dVRjanpPVnNybWpjNzY5d1d5bTVTaUtPOG5UN1A5RzUtTmNhZ1ZRQVR5cU43TUpVcDd3ck01ODFzQU9hcnBEMU1rOHExY3VPQ1p5aXBxdDhn?oc=5","date":"2026-03-10","type":"pipeline","source":"Stock Titan","summary":"She helped sell a biotech to Roche — now she’s joining MBX - Stock Titan","headline":"She helped sell a biotech to Roche — now she’s joining MBX","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxQZ2wtbkpRbm5TQnd4cEEtbDc3UDJ2UWdWdk9NdGJBbUtPUXFZY0RNZk1EQWtSaDJidnpRRmw0bDdiYjdHTjUtb09CUXpzazZfMUV2SzVxT0RBcGh4dGhXd1daSlJGazVLeTAwUWFnUkgtcVZuSktzUGFORUVoTjRnZ3JNQlJRR0pjMWtYTTFiYWd3TkJQNVFRMFdBSllqVzdXU2gtenF3R1NPN19iLTRPaXNtc2pNeFl4VGRGRjE0RXhNNVg0ZV8wZWE3Y0dHRDdMN0E?oc=5","date":"2026-03-10","type":"pipeline","source":"GlobeNewswire","summary":"MBX Biosciences Appoints Karen Basbaum as Chief Business Officer - GlobeNewswire","headline":"MBX Biosciences Appoints Karen Basbaum as Chief Business Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxPMENxN3lkY1ZYdHUtQWRJUWtVbFVpYUlzcnItbkF2VEJ2WVNxYjdvSFZrd1VuTUVnVkhlQlVsclNuQTJ6OUdBRzR1VG5WNW9yazBZamFrMXY0aHVEWUh5LW93SGtiMUZxMUhCb2dGZGdaTVZoRTlRQ2xDeFlaVktRTjMtRHpIc1RtREhqcFNlYnBKWHVzZHAxTTR2dVpjZE5EWndUOHJySVBvX01ESGE3QlVDckdoU0NHZ3J4SEExSHF4bzU1ZWc?oc=5","date":"2025-09-22","type":"trial","source":"Endpoints News","summary":"MBX Biosciences shares Phase 2 hypoparathyroidism data as it seeks to compete with Ascendis, AstraZeneca - Endpoints News","headline":"MBX Biosciences shares Phase 2 hypoparathyroidism data as it seeks to compete with Ascendis, AstraZeneca","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE5tOGxVOWV1YnNPNGxXSnFqTFZPalhDR21wSFo4aUFtY1RLX0gzVnd5T256UnNacGhDWUJZaUtFWWxJU0F1dWl2WUdpWjJjQ2hiVE8w?oc=5","date":"2025-09-22","type":"trial","source":"FirstWord Pharma","summary":"MBX's weekly hypoparathyroidism drug hits key goals in Phase II - FirstWord Pharma","headline":"MBX's weekly hypoparathyroidism drug hits key goals in Phase II","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7wFBVV95cUxPMWxuMFg5VTlYbjNieHJqb0FyNDdVNlZ4NEItZmlzS0FzWG1ZY3ZZa2NPZXNybm9aTjBycUZ3R3ZvUERveFE3SFhkR0FIY0p1MXlKLTl3R2NtMlp3U0Z0dzFKN3M3Z3dDeDVlSXJlSDNzM0NyNV96Z25GOVhvTWZhZU56WXRRY0Z0WGU2M3AzTUNKOF9UMXlqNDQwUkoyZnNjVzJQTjNzVjB3VU9NOFUwOUtIYXFkREtSSHV1T1NkdjZXV2pTQ1QtR0xLZHlaN0xyM2ZsS241dkFxR1NibEZlcF9nSkR5ZXJPS1YtSWJvbw?oc=5","date":"2025-09-22","type":"trial","source":"Citeline News & Insights","summary":"MBX Surges As Phase II Data Show Competitive Profile For Canvuparatide - Citeline News & Insights","headline":"MBX Surges As Phase II Data Show Competitive Profile For Canvuparatide - Citeline News & Insights","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxNeGsyTW56djBpV0hoSy04a2FIYVE2Nm5FYWJYYzJXVXdGQXZUbXlXWWZ4RldzQWNxUThidUJ4TGtJM3RKVVBrcUZaVFM1LVg4U0NKR1Q0RnI3MHpYcjlPb1kxbzRIUXhYZUxPYzlCb0NnbmUtS3RydEhTbnRMQjBnV2JOVE5MZHVCYm1FNlQ1MktHYjltYUl5cGIxQUo2dFFaX2xaa3NJOExkT012?oc=5","date":"2025-09-22","type":"trial","source":"statnews.com","summary":"MBX hormone replacement shows efficacy in mid-stage study - statnews.com","headline":"MBX hormone replacement shows efficacy in mid-stage study","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTE9XUW96WEpXc3pNaU10UzlFNkJ1UlN2RXFDekFQamtNUUJvSElNdzhRSDVESUpiSFptVG9ZY0g1Q2RhMkdrZWktRldwS1BkMXpTR3U0WnJQNUtDaHhGUE9FWW5vcHJOQ2RRS3BmZFlLWk1DNWtJMjcyRktVWTZvclk?oc=5","date":"2025-08-24","type":"pipeline","source":"MarketBeat","summary":"Top MBX Biosciences (MBX) Competitors 2026 - MarketBeat","headline":"Top MBX Biosciences (MBX) Competitors 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxOb1NXY1FydTktUndMNC1ob0t6YmVvODlSVHIyVFo1bnh1aVQ5ZkhkZXpQUWczd19HQmluZVNoQ0xfbm1rZ0hycmdMdmpOSTdINERKd056T25GYm9DVGM5alZJSkNES1FSRDNuU2hQdmF5SV81RjBRV25fWEhDSWhDVjFTNDk4MjZBYTNsSHdCS2pfNm04ei1JZVFIRzNDYjhlSXNQTk9CV3ZEQms1Nlo4QjJJZ2h0MnR2UHUw?oc=5","date":"2025-05-31","type":"deal","source":"seekingalpha.com","summary":"MBX Biosciences: Consider Peptide Developer With GLP Drugs As A Speculative Buy - seekingalpha.com","headline":"MBX Biosciences: Consider Peptide Developer With GLP Drugs As A Speculative Buy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxQa2EydXJMYnlzSGNvZ2pzYy1GMEgzNXo4a1dTb2ZYZjRMazJmS0VzNjBGZFhhQ3o5cGthSEpMRm9ScmJHd0NJQ1JmZnpsRDNGZlo2cnNxZEZHYnNNYU0tY3pyeHBmdC1hTk51ZnJJR2Rud1dsbU45UEdPRS1jT3I3MTBCYXp3YmtXV0ZndnRLOVBmdGlFaUgzaXpmTWoxRFFoUmVEemZCRFJfRURSVnVDVUh2bFRmVW1kNmJFX0tNWQ?oc=5","date":"2024-09-09","type":"pipeline","source":"Reuters","summary":"MBX Biosciences seeks up to $482.5 mln valuation in US IPO - Reuters","headline":"MBX Biosciences seeks up to $482.5 mln valuation in US IPO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxQU25kZ19PdWd5aWUzR0dfYXpxTXZ4bXp1ZTJ2eERRZVZxWnA0dERmV3ZFTVhkbFFEYkFobC1sVmxqSDEzdXd2RmNCRzhiYnlMWUlQVGp1UUhVYlk3Sy1MbmxPdDAtX3EzVVFUQzQ5WVVvR0k3cF9FX3BEUEhxaXl0T2xCakhfcFI2MzdXenNiZDc?oc=5","date":"2024-08-06","type":"pipeline","source":"The Pharma Letter","summary":"MBX Biosciences raises $63.5 million in Series C financing - The Pharma Letter","headline":"MBX Biosciences raises $63.5 million in Series C financing","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_2":1,"phase_1":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}